Professional Documents
Culture Documents
TOPICs
Why ?
History
Important
Of PICs
GMP Guide
Document
PE -009
Chapter
4,6
Doc Type
Annex 15
Doc Control
Syst. & Life
cycle
CREATION
CONCEPTs
&
Model
GOOD DOCUMENTs
9/19/2016
1 January 2013
PE 009-10
1 March 2014
PE 009-11
1 Oct 2015
9/19/2016
PE 009-12
Revision of Annex 15
(PE 009-12)
Introduction
PART I
: CHAPTER 4 DOCUMENTATION
: CHAPTER 6 (6.7-6.10 ) QC DOCUMENTATION
CHAPTER 4: DOCUMENTATION
-
V.9
Stronger emphasis
on holistic
compliance
Type of Documents
Retention period
V.11
V.10
*Big
Change
V.12
Chapter4 DOCUMENTATION
Principle
Required GMP Documentation (by Type)
Generation and Control Documentation
Good Documentation Practices
Retention of Documents
Specifications
Manufacturing Formula and Processing /Packaging Instruction
Batch Processing Record
Packaging Record
Procedures and Records
Receipt
Sampling
Testing
Others
CHAPTER 4 DOCUMENTATION
PRINCIPLE
The main objective of the system of documentation
utilized must be to establish, control, monitor, and record
all activities which directly or indirectly impact on all
aspects of the quality of medicinal products.
To ensure the accuracy, integrity, availability and
legibility of document
There are two types of documents used to manage and
record GMP compliance:
Instructions (direction, req.):free from error, available in writing
Records/Reports : be rendered in a human readable
form.
CHAPTER 4 DOCUMENTATION
REQUIRED GMP DOCUMENT (BY TYPE)
Site Master File
A document describing the GMP related activities of the
manufacturer.
Record/Report type
Instructions type
Specifications
Protocols
Reports
Procedures
Technical
Agreement
Records
Certificate of
Analysis
Alternatively the
certification may be
based, in-whole or inpart, on the assessment
of the real timed data
from batch related PAT.
CHAPTER 4 DOCUMENTATION
GENERATION AND CONTROL OF DOCUMENTATION
4.1
Many documents (instructions and/or records) may exist in hybrid
forms, i.e. some elements as electronic and others as paper based.
Relationships and control measures for master documents, official
copies, data handling and records need to be stated for both
hybrid and homogenous systems.
CHAPTER 4 DOCUMENTATION
GENERATION AND CONTROL OF DOCUMENTATION
4.2
Document should be designed, prepared, reviewed, and
distributed with care.
They should comply with the relevant parts of Product specification
files, Manufacturing and marketing authorization dossiers.
The reproduction of working documents from master documents
should not allow any error to be introduced through the
reproduction process.
CHAPTER 4 DOCUMENTATION
GENERATION AND CONTROL OF DOCUMENTATION
4.3
Documents containing instructions should be approved, signed and date by
appropriate and authorized persons.(Qualified :EU )
Documents should have unambiguous contents and be uniquely identifiable. The
effective should be defined.
4.4
Document containing instructions should be laid out in an orderly fashion and be
easy to check
4.5
Documents within the QMS should be regularly review and kept up-to-date.
When a document has been revised, systems should be operated to prevent
inadvertent use of superseded documents.
4.6 Documents should not be hand written, .sufficient space
should be provided for such entries.
CHAPTER 4 DOCUMENTATION
GOOD DOCUMENTATION PRACTICE
4.7 Handwritten : clear, legible, indelible way
4.8 Records : at the time each action, traceable
4.9 Alteration : signed and dated
permit the reading of the original information
the reason for the alteration should be recorded
CHAPTER 4 DOCUMENTATION
RETENTION OF DOCUMENT
4.10
Records is located, ensure the integrity, validated
4.11
Specific requirements apply to batch documentation which must be kept for one
year after expiry of the batch to which it relates or at least five years after
certification of the batch by the Authorized Person, whichever is longer.
4.12
For other types of documentation, the retention period will depend on the
business activity which the documentation supports. Critical documentation,
including raw data (for example relating to validation or stability), which support
information in the Market Authorization should be retained whilst the
authorization remains in force. It may be considered acceptable to retire certain
documentation where the data has been superseded by a full set of new data.
CHAPTER 4 DOCUMENTATION
SPECIFICATIONS 4.13-16
Starting and
Packaging Materials
Intermediate and
Bulk Products
Finished Products
CHAPTER 4 DOCUMENTATION
SPECIFICATIONS
Intermediate and Bulk Products:
Should be available for critical steps or if these are purchased or
dispatched. The specifications should be similar to specifications for
starting materials or for finished products, as appropriate.
Finished Products:
as starting
+ The Formula
+ Storage conditions and special handling precautions, where
application
+ The shelf life
CHAPTER 4 DOCUMENTATION
MANUFACTURING FORMULA AND PROCESSING INSTRUCTIONS 4.17-4.21
Approved, written Manufacturing Formula and Processing Instructions should exist
for each product and batch size to be manufactured.
Manufacturing Formula
Should include :
a)
The name of the product, with a product reference code relating to its specification
b)
A description of the pharmaceutical form, strength of the product and batch size
c)
A list of all starting materials to be used, with the amount of each, described; mention
should be made of any substance that may disappear in the course of processing;
d)
A statement of the expected final yield with the acceptable limits, and of relevant
CHAPTER 4 DOCUMENTATION
Processing
Instructions
Packaging
Instructions
Batch Processing
Record
Batch Packaging
Record
CHAPTER 4 DOCUMENTATION
Batch Processing
Record
++ Formula + Instruction
(4.22-4.24)
each delivery of starting material, Intermediate, primary, secondary
and printed PM
Record + COA , supplier, manufacturer
Sampling
Testing (4.26)
+ Chapter 6 QC testing
SOP at different stage ;approved method, equipment
Record (6.17)
Complaints
Returns
Recalls
Change Control
Investigation into deviations and nonconformances
Internal quality / GMP compliance
audits
Summaries of records where
appropriate (e.g. product quality
review)
Supplier audit
Specifications
Sampling procedures +Annex8
Testing Procedures and Records
Analytical Reports and/or certificates
Data from environmental monitoring, where required
Validation records of test methods, where applicable
Procedures for and records of the calibration of
instruments and maintenance of equipment.
6.10
In addition to the information which is part of the batch record, other
original data such as laboratory notebooks and/or records should
be retained and readily available.
Part II Chapter 6
TRAINING
(plan, OJT)
Internal document:
Numbering System
Type of document
Sequential number
Document Number
Sequential number
of the form
DOCUMENT
CREATION/REVISION
All new or revised documents must pass
through the document approval process by
using the Document Action Request
DOCUMENT
REQUEST & DISTRIBUTION
The hard copies both Controlled and Uncontrolled can be requested by using
Document Request Form.
DOCUMENT CANCELLATION
The Document Preparer or Designee must be completed a
DAR Form when he/she wants to cancel a controlled
document. Approval signatures must include the following at
minimum:
Document Preparer
Responsible Manager
DOCUMENT RETENTION
PINK DOCUMENT
In training and trial period, the DCC will generate the
documents for training purposes ::: Signed & Copied on
Pink paper.
Purposes of pink paper are also warning the operator who
read them, these instructions have some changes. They
will stay in pink paper for a month.
TITLE
Document No.
SOP-QA-001
Rev. 02
Eff. Date:
4 Jul 2014
DEPARTMENT
QUALITY ASSURANCE
PAGE 12 of 24
Document No.
SOP-EN-001
Rev.01
Eff. Date :
20 Oct 2013
DEPARTMENT
ENGINEERING DIVISION
PAGE 1 of 10
TITLE
Document No.
SOP-QA-001_Annex01
Rev.02
Eff. Date :
4 Jul 2014
DEPARTMENT
QUALITY ASSURANCE
PAGE 4 of 5
DOCUMENT FORMAT :
Distribution List
Copy No.
Master
Area / Position
Document Control Center - QA
QA Manager
01
Initial Release
02
Revised:
Header: Change the plant name from
Rangsit Manufacturing Plant to Rangsit
Pharmaceutical Production Plant.
Rearrange the sequence of topics.
Distribution List: Rename and add the newly
divisions and sections as per the approved
organization chart. (p. 2/23)
Internal Document Control System: remove
the section of Numbering System. (p. 10/23)
Internal Document Control System: change
the process and lifecycle of pink document.
(p. 10/23)
Attachment: remove template of VMP, QM,
BPR, SOP
Release in white paper
Revised:
- Updated the format of document header for
using in eQMS.
- Add definition of term that used in eQMS.
- Add detail for document control procedure in
eQMS
- Cancel the use of pink document
- Cancel the use of SOP-QA-001_Annex04
02
03
Effective
Date
19 Sep 2011
4 Jul 2014
4 Aug 2014
As per an
effective
date in
electronic
system
IMPLEMENTATION:DOCUMENT MODEL
Level 1
Level 2
Procedures (SOPs)
Procedures
Level 3
Operation Instructions
Level 4
Work Instructions
How
6
Quality
System
Personnel
Facilities,
Utilities &
Equipment,
IT/Comp.
Documentation
Laboratory
System
Production
Materials
Packaging&
Labeling
SMF PE008-4
EXPLANATORY NOTES FOR PHARMACEUTICAL MANYFACTURERS
ON THE PREPARATION OF A SITE MASTERFILE
1.
2.
3.
PERSONNEL
4.
5.
DOCUMENTATION
6.
PRODUCTION
7.
8.
9.
SELF INSPECTIONS
SMF PE008-4
EXPLANATORY NOTES FOR PHARMACEUTICAL MANYFACTURERS ON
THE PREPARATION OF A SITE MASTERFILE
Contents 5. Documentation
Description of documentation system (i.e. electronic ,manual)
When documents and records are stored or archived off-site
(including pharmacovigilance data when applicable)
List of types of documents/records
Name and address of storage site and estimate of time required
retrieving documents from the off-site archive
SMF PE008
Appendix 1 Copy of valid manufacturing authorisation
Appendix 2 List of dosage forms manufactured including the INN-names or
common name (as available) of active pharmaceutical ingredients (API) used
Appendix 3 Copy of valid GMP Certificate
Appendix 4 List of contract manufacturers and laboratories including the
addresses and contact information, and flow-charts of the supplychains for
these outsourced activities
Appendix 5 Organisation charts
Appendix 6 Lay outs of production areas including material and personnel
flows, general flow charts of manufacturing processes of each product type
(dosage form)
Appendix 7 Schematic drawings of water systems
QM
Quality Manuals
What does the document contain?
The Quality Manual is the overarching document of the QMS used
to describe:
the quality policy of the business entity
the boundaries, operations and process improvement of the QMS
throughout the product lifecycle
management responsibilities
the road map of the key processes of the QMS and their relationship to
each other.
The Quality Manual may encompass multiple sites or a business entity
operating within a larger site. Larger companies may not have a single
document, or even call it a Quality Manual, but implement the quality policy
using a series of individual documents this is perfectly acceptable. Smaller
companies may use the Quality Manual alone to describe their QMS
(particularly in ISO 9001, though not so much in pharmaceutical companies).
No (but preferred)
No specific requirement
EU GMP
PIC/S GMP version 10
No specific requirement
No specific requirement
Yes
Yes
SMF Checklist
ANNEX15 VALIDATION
ANNEX15 VALIDATION
The VMP or equivalent document should define the
qualification/validation system and include or reference
information on at least the following:
I.
IV.
II.
V.
Guidance on developing
acceptance criteria
VI.
VII.
III.
ANNEX15 VALIDATION
DOCUMENTATION, INCLUDING VMP (2.1-2.10)
2.1 To support Km throughout the product lifecycle
ANNEX15 VALIDATION
2.6
Where validation protocols and other documentation are
supplied by a third party providing validation services,
appropriate personnel at the manufacturing site should
confirm suitability and compliance with internal procedures
before approval.
ANNEX15 VALIDATION
2.7
Any significant changes to the approved protocol during
execution, e.g. acceptance criteria, operating parameters
etc., should be documented as a deviation and be
scientifically justified.
2.8
Results which fail to meet the pre-defined acceptance criteria
should be recorded as a deviation, and be fully investigated
according to local procedures. Any implications for the
validation should be discussed in the report.
2.9
The review and conclusions ; against criteria/justification
change/recommendation
ANNEX15 VALIDATION
2.10
A formal release for the next stage in the qualification and
validation process should be authorized by the relevant
responsible personnel either as part of the validation
report approval or as a separate summary document.
Conditional approval to proceed to the next qualification
stage can be given where certain acceptance criteria or
deviations have not been fully addressed and there is a
documented assessment that there is no significant
impact on the next activity
LIST OF PROCEDURES
Laboratory
QMS
PERMIT TO OPERATE
/ (CAPA SYSTEM)
(Failure Investigation)
(Batch Release)
Incident Report
Investigating Out of Specification /Out of Trend Test
Results and control of Non-Conformance
Supplier Approval and Evaluation System
(Returned and Salvaged Drug Products)
(Recall Procedure)
Customer Complaint
Record (CCR)
(Item Number)
Packaging and Printing Material Supplier
Approval and Evaluation
(Product Specification)
Analytical Results and Trends
LIST OF PROCEDURES
Production
Penicillin
Lot No.
Material
VMI
/
LIST OF PROCEDURES
Personnel
Shut Down
(Purified Water)
Computer System
GMP
CREATION CONCEPTs
REGULATION
REGULATION
RECORDS
&
REPORTS
5R
RESOURCE
RESPONSI
BILITY
RESPONSIBILITY
Clear authorization
RESOURCE
RISK
RISK
Validation/Deviation /CAPA/change
Traceability
GOOD DOCUMENTS
siri_van@gpo.or.th